-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 P+LQdngoQlXiNsC9lqGhhKSdnrhF/wFsNDlei73hiVoLcpKmtYlndZ73WWNJHVxV
 ZdaHndOElO0USOvQpB1zgw==

<SEC-DOCUMENT>0000200406-04-000128.txt : 20041004
<SEC-HEADER>0000200406-04-000128.hdr.sgml : 20041004
<ACCEPTANCE-DATETIME>20041004094949
ACCESSION NUMBER:		0000200406-04-000128
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20041001
ITEM INFORMATION:		Other Events
FILED AS OF DATE:		20041004
DATE AS OF CHANGE:		20041004

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			JOHNSON & JOHNSON
		CENTRAL INDEX KEY:			0000200406
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				221024240
		STATE OF INCORPORATION:			NJ
		FISCAL YEAR END:			0103

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-03215
		FILM NUMBER:		041060352

	BUSINESS ADDRESS:	
		STREET 1:		ONE JOHNSON & JOHNSON PLZ
		CITY:			NEW BRUNSWICK
		STATE:			NJ
		ZIP:			08933
		BUSINESS PHONE:		7325242454
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>eightkcover.txt
<TEXT>


               SECURITIES AND EXCHANGE COMMISSION
                     Washington, D.C. 20549


                            FORM 8K

       Current Report Pursuant to Section 13 or 15(d) of
              The Securities Exchange Act of 1934



Date of Report (Date of earliest event reported): October 1, 2004


                        JOHNSON & JOHNSON

     (Exact name of registrant as specified in its charter)


    New Jersey              1-3215               22-1024240

(State or other           Commission         (I.R.S. Employer
jurisdiction              File Number)       Identification No.)
of incorporation)



 One Johnson & Johnson Plaza, New Brunswick, New Jersey   08933

           (Address of principal executive offices)    (zip code)


Registrant's telephone number including area code: (732) 524-0400


Item 8.01.   Other Events.

On October 1, 2004, Johnson & Johnson ("J&J") announced the
redemption of 8.72% debentures due November 2024.




(c)  Exhibit

Exhibit No.       Description of Exhibit

Exhibit 99.17  Press Release dated October 1, 2004.




                            SIGNATURE



Pursuant to the requirements of the Securities Exchange Act of
1934,  the registrant has duly caused this report to be signed
on its behalf by the undersigned hereunto duly authorized.



                                   JOHNSON & JOHNSON




Date: October 1, 2004         By:
                              Stephen J. Cosgrove
                              Chief Accounting Officer




</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.17 (AS APPROP)
<SEQUENCE>2
<FILENAME>eightkninetynineseventeen.txt
<TEXT>
Exhibit 99.17

 Johnson & Johnson Announces Redemption of 8.72% Debentures
                      Due November 2024

NEW BRUNSWICK, N.J., Oct 1, 2004 /PRNewswire-FirstCall via
COMTEX/ -- Johnson & Johnson (NYSE: JNJ) announced today
that it has exercised its option to redeem all of its
$300,000,000 aggregate principal amount of 8.72% Debentures
due 2024 (the "Debentures") that remain outstanding on the
redemption date, November 1, 2004.

The redemption price is 104.360% of the principal amount of
the Debentures or $1,043.36 per $1,000 principal amount of
Debentures, with accrued interest to the date of redemption
(subject to the right of holders of record on the record
date to receive interest due and accrued through such date
of redemption). Redemption terms and conditions are being
provided by the trustee, BNY Midwest Trust Company.

Johnson & Johnson issued these Debentures in 1994 in an
aggregate principal amount of $300 million.

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
